Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06888024 · ClinicalTrials.gov registry record · NA
Pelvic Vein Quantitative Flow Characterization Using 2D and 4D Flow MRI
A NA study of May-Thurner Syndrome and Iliac Venous Compression, sponsored by Ningcheng Peter Li.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06888024: Recruiting NA study of May-Thurner Syndrome and Iliac Venous Compression, sponsored by Ningcheng Peter Li.
NCT06888024 is a NA study of May-Thurner Syndrome and Iliac Venous Compression that is actively recruiting participants, run by Ningcheng Peter Li. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06888024, a NA study of May-Thurner Syndrome and Iliac Venous Compression, is actively recruiting participants, sponsored by Ningcheng Peter Li.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to quantitatively characterize the flow in the pelvic venous structures using 2D and 4D flow MRI with the objective of establishing physiologic and pathologic parameters for downstream computational fluid dynamics analysis. Arm 1: To establish the baseline flow characteristics of the iliac veins in patients with no imaging evidence of iliac venous disease. Arm 2: To assess the flow characteristics of the iliac veins in patients with left iliac vein compression syndrome (a.k.a. May-Thurner syndrome). Arm 3: To assess the flow characteristics of the iliac veins in patients status post iliac stent placement.
Primary Outcome
Flow volume in the iliac veins calculated based on the 2D and 4D flow MRI obtained.
Conditions Studied
Interventions
- PROCEDURE non-contrast enhanced abdomen and pelvis MRI
Study Locations (1)
Massachusetts
- University of Massachusetts - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
What NCT06888024 shows while recruiting
NCT06888024 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with May-Thurner Syndrome appearing as the primary indexed condition, and to 1 intervention - of which non-contrast enhanced abdomen and pelvis MRI is the first listed.
NCT06888024 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06888024 about?
NCT06888024 is a clinical study titled "Pelvic Vein Quantitative Flow Characterization Using 2D and 4D Flow MRI". The purpose of the study is to quantitatively characterize the flow in the pelvic venous structures using 2D and 4D flow MRI with the objective of establishing physiologic and pathologic parameters for downstream computational fluid dynamics analysis. Arm 1: To establish the baseline flow character...
What is the current status of trial NCT06888024?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-04-01. Estimated completion is 2027-01-01.
What conditions does trial NCT06888024 study?
This clinical trial studies the following conditions: May-Thurner Syndrome, Iliac Venous Compression.
What interventions are being tested in trial NCT06888024?
The interventions under investigation include: non-contrast enhanced abdomen and pelvis MRI (PROCEDURE).
Who is sponsoring clinical trial NCT06888024?
This trial is sponsored by Ningcheng Peter Li, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06888024 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for May-Thurner Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06888024's enrollment target sits among peer trials
15 1882nd of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI